Skip to main content

Balyasny Asset Management L.P.

Position in LNTH — Lantheus Holdings, Inc.

CIK 1218710 Chicago, IL

Position in LNTH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$30,821,461
-$10,090,663 QoQ
Shares Held
277,821
-48.5% QoQ
Ownership
0.426%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#49
of 467 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Derivatives in LNTH

reported options exposure · as of Jun 30, 2025
CallValue
$335,626
CallShares
4,100
PutValue
$278,324
PutShares
3,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $126,095,704 across 18 Drug Manufacturers - Specialty & Generic names. LNTH ranks #1 (24.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LNTH
Lantheus Holdings, Inc.
This page
277,821 $30,821,461

All Filings in LNTH

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,821,461 277,821
2026-03-31 $40,912,124 539,382
2025-12-31 $9,368,975 140,781
2025-09-30 $1,468,124 28,624
2025-06-30 $335,626 4,100
2025-06-30 $278,324 3,400
2025-06-30 $622,381 7,603
2025-03-31 $827,160 8,475
2024-12-31 $3,328,090 37,202
2024-09-30 $1,492,600 13,600
2024-09-30 $1,536,500 14,000
2024-09-30 $13,909,166 126,735
2024-06-30 $1,525,510 19,000
2024-06-30 $35,973,613 448,046
2024-06-30 $1,372,959 17,100
2024-03-31 $9,780,331 157,139
2023-12-31 $49,020,238 790,649
2023-09-30 $50,748,816 730,409
2023-06-30 $36,224,151 431,651
2023-03-31 $31,188,195 377,764
2022-12-31 $16,969 333
2020-03-31 $142,248 11,148